FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

EIGER BIOPHARMACEUTICALS, INC.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2020-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/7356c8cc-6b83-46cb-8f5b-41e4603a430a

Reported value

$22.629M{"amount": 22629000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
EIGER BIOPHARMACEUTICALS, INC.
Metric
cash_and_equivalents
Period
as of 2020-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001564590-20-022884 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T12:26:36.885058+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001305253/cash-and-equivalents/2020-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.